Statera Biopharma, Inc. (STAB)

USD 0.0

(0.0%)

Total Assets Summary of Statera Biopharma, Inc.

  • Statera Biopharma, Inc.'s latest annual total assets in 2021 was 21.16 Million USD , up 1944.42% from previous year.
  • Statera Biopharma, Inc.'s latest quarterly total assets in 2022 Q3 was 12.74 Million USD , down -5.86% from previous quarter.
  • Statera Biopharma, Inc. reported annual total assets of 1.03 Million USD in 2020, up 62656.67% from previous year.
  • Statera Biopharma, Inc. reported annual total assets of 1650.00 USD in 2019, down -99.96% from previous year.
  • Statera Biopharma, Inc. reported quarterly total assets of 13.5 Million USD for 2022 Q1, down -36.18% from previous quarter.
  • Statera Biopharma, Inc. reported quarterly total assets of 13.54 Million USD for 2022 Q2, up 0.24% from previous quarter.

Annual Total Assets Chart of Statera Biopharma, Inc. (2021 - 2006)

Historical Annual Total Assets of Statera Biopharma, Inc. (2021 - 2006)

Year Total Assets Total Assets Growth
2021 21.16 Million USD 1944.42%
2020 1.03 Million USD 62656.67%
2019 1650.00 USD -99.96%
2018 4.53 Million USD -52.91%
2017 9.62 Million USD -39.65%
2016 15.95 Million USD -23.59%
2015 20.88 Million USD -99.41%
2014 3.54 Billion USD -75.86%
2013 14.69 Billion USD -54.09%
2012 32.01 Billion USD 99535.92%
2011 32.12 Million USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Total Assets Comparison of Statera Biopharma, Inc.

Name Total Assets Total Assets Difference
America Great Health 299.12 Thousand USD -6977.109%
Ampio Pharmaceuticals, Inc. 5.73 Million USD -269.067%
Aridis Pharmaceuticals, Inc. 14.69 Million USD -44.06%
Biora Therapeutics, Inc. 31.21 Million USD 32.181%
Bio-Path Holdings, Inc. 3.22 Million USD -557.444%
Better Therapeutics, Inc. 22.94 Million USD 7.729%
Calithera Biosciences, Inc. 28.67 Million USD 26.176%
Comera Life Sciences Holdings, Inc. 3.72 Million USD -467.991%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. 20.54 Million USD -3.046%
Eloxx Pharmaceuticals, Inc. 21.12 Million USD -0.221%
Evelo Biosciences, Inc. 64.44 Million USD 67.149%
Evolutionary Genomics, Inc. 2.35 Million USD -799.418%
Finch Therapeutics Group, Inc. 70.99 Million USD 70.182%
Galera Therapeutics, Inc. 26.14 Million USD 19.017%
Innovation1 Biotech Inc. 75.99 Thousand USD -27757.414%
Kiromic BioPharma, Inc. 12.16 Million USD -73.964%
Molecular Templates, Inc. 35.38 Million USD 40.17%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD -384.254%
NexImmune, Inc. 8.59 Million USD -146.332%
Orgenesis Inc. 14.55 Million USD -45.476%
Panbela Therapeutics, Inc. 11.8 Million USD -79.374%
Point of Care Nano-Technology, Inc. 124.64 Thousand USD -16884.255%
PaxMedica, Inc. Common Stock 5.68 Million USD -272.679%
Scopus BioPharma Inc. 392.26 Thousand USD -5296.782%
Sorrento Therapeutics, Inc. 472.84 Million USD 95.523%
TRACON Pharmaceuticals, Inc. 10.1 Million USD -109.497%
Trevena, Inc. 40.6 Million USD 47.864%
Vaxxinity, Inc. 44.35 Million USD 52.27%
Vaccinex, Inc. 3.63 Million USD -483.026%
Vicapsys Life Sciences, Inc. 39.65 Thousand USD -53283.309%
Viracta Therapeutics, Inc. 56.69 Million USD 62.658%
ZIVO Bioscience, Inc. 555.71 Thousand USD -3709.45%